Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2021

Open Access 01-12-2021 | Schizophrenia | Research

EQ-5D-5L in Schizophrenia: differences between patients and nurses’ reports

Authors: Fredrick Dermawan Purba, Yusi Anggriani, Tri Murtini

Published in: Health and Quality of Life Outcomes | Issue 1/2021

Login to get access

Abstract

Purpose

To examine the differences between patient-reports and proxy-reports by nurses of EQ-5D-5L responses among patients with schizophrenia.

Methods

This study was conducted in June–September 2019 in Duren Sawit Regional Public Hospital in Jakarta, Indonesia. The self-report data were obtained by interviewing the patients and the proxy-report data were obtained from the psychiatric nurses. The patients’ Positive and Negative Syndrome Scale (PANSS) scores were obtained from their medical records. The data were collected in two time points: (1) when the patients moved from the acute to the quiet rooms (first-test) and (2) when they were discharged from the hospital (second-test). The self and proxy report scores were analysed by the Wilcoxon matched-pairs signed-ranks test and their relationship with the PANSS scores using Spearman's rank correlation coefficient.

Results

There were 206 patients in the final sample. The majority are male (56.8%) with a mean age of 37.5 years (SD = 12.05). Significant differences between the two reports were found in three domains (i.e., self-care, usual activities, and pain/discomfort) in the first-test and two domains (i.e., usual activities and pain/discomfort) in the second-test. Concerning the relationship with the PANSS scores, only three significant correlations were found, all in the proxy-version and in the second-test: mobility (r = 0.139), anxiety/depression (r = 0.2523), and utility scores (r = − 0.176).

Conclusions

The poor-to-fair agreement between patients and nurses reports and the poor correlation with the PANSS scores suggested that it is difficult to decide which report best represents the patients’ health status.
Literature
1.
go back to reference Drummond M, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes (Fourth edition). Oxford: Oxford University Press; 2015. Drummond M, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes (Fourth edition). Oxford: Oxford University Press; 2015.
2.
go back to reference Kennedy-Martin M, Slaap B, Herdman M, van Reenen M, Kennedy-Martin T, Greiner W, Busschbach J, Boye KS: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics 2020. Kennedy-Martin M, Slaap B, Herdman M, van Reenen M, Kennedy-Martin T, Greiner W, Busschbach J, Boye KS: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics 2020.
3.
go back to reference Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef
4.
go back to reference Devlin N, Parkin D, Janssen B. Methods for Analysing and Reporting EQ-5D Data. Berlin: Springer; 2020.CrossRef Devlin N, Parkin D, Janssen B. Methods for Analysing and Reporting EQ-5D Data. Berlin: Springer; 2020.CrossRef
5.
go back to reference Setiawan D, Dusafitri A, Galistiani GF, van Asselt ADI, Postma MJ. Health-related quality of life of patients with HPV-related cancers in Indonesia. Value Health Region Issues. 2018;15:63–9.CrossRef Setiawan D, Dusafitri A, Galistiani GF, van Asselt ADI, Postma MJ. Health-related quality of life of patients with HPV-related cancers in Indonesia. Value Health Region Issues. 2018;15:63–9.CrossRef
6.
go back to reference Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, Pickard AS. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24(4):845–50.CrossRef Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, Pickard AS. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24(4):845–50.CrossRef
7.
go back to reference Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28(4):395–413.CrossRef Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28(4):395–413.CrossRef
8.
go back to reference Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? Syst Rev Value Health. 2011;14(6):907–20.CrossRef Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? Syst Rev Value Health. 2011;14(6):907–20.CrossRef
9.
go back to reference Pitkänen A, Välimäki M, Endicott J, Katajisto J, Luukkaala T, Koivunen M, Kuosmanen L, Hätönen H. Assessing quality of life in patients with schizophrenia in an acute psychiatric setting: reliability, validity and feasibility of the EQ-5D and the Q-LES-Q. Nord J Psychiatry. 2012;66(1):19–25.CrossRef Pitkänen A, Välimäki M, Endicott J, Katajisto J, Luukkaala T, Koivunen M, Kuosmanen L, Hätönen H. Assessing quality of life in patients with schizophrenia in an acute psychiatric setting: reliability, validity and feasibility of the EQ-5D and the Q-LES-Q. Nord J Psychiatry. 2012;66(1):19–25.CrossRef
10.
go back to reference Prieto L, Sacristán JA, Hormaechea JA, Casado A, Badia X, Gómez JC. Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin. 2004;20(6):827–35.CrossRef Prieto L, Sacristán JA, Hormaechea JA, Casado A, Badia X, Gómez JC. Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin. 2004;20(6):827–35.CrossRef
11.
go back to reference Abdin E, Chong SA, Seow E, Peh CX, Tan JH, Liu J, Hui SFS, Chua BY, Sim K, Verma S, et al. A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore. Psychiatry Res. 2019;274:400–8.CrossRef Abdin E, Chong SA, Seow E, Peh CX, Tan JH, Liu J, Hui SFS, Chua BY, Sim K, Verma S, et al. A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore. Psychiatry Res. 2019;274:400–8.CrossRef
12.
go back to reference Atkinson M, Zibin S Fau - Chuang H, Chuang H: Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. (0002–953X (Print)). Atkinson M, Zibin S Fau - Chuang H, Chuang H: Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. (0002–953X (Print)).
13.
go back to reference Griffiths AW, Smith SJ, Martin A, Meads D, Kelley R, Surr CA. Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes. Qual Life Res. 2020;29(2):463–72.CrossRef Griffiths AW, Smith SJ, Martin A, Meads D, Kelley R, Surr CA. Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes. Qual Life Res. 2020;29(2):463–72.CrossRef
14.
go back to reference Sainfort F, Becker M, Diamond R. Judgments of quality of life of individuals with severe mental disorders: patient self-report versus provider perspectives. Am J Psychiatry. 1996;153(4):497–502.CrossRef Sainfort F, Becker M, Diamond R. Judgments of quality of life of individuals with severe mental disorders: patient self-report versus provider perspectives. Am J Psychiatry. 1996;153(4):497–502.CrossRef
15.
go back to reference Dey M, Landolt MA, Mohler-Kuo M. Assessing parent–child agreement in health-related quality of life among three health status groups. Soc Psychiatry Psychiatr Epidemiol. 2013;48(3):503–11.CrossRef Dey M, Landolt MA, Mohler-Kuo M. Assessing parent–child agreement in health-related quality of life among three health status groups. Soc Psychiatry Psychiatr Epidemiol. 2013;48(3):503–11.CrossRef
16.
go back to reference Clark BG, Magill-Evans JE, Koning CJ. Youth with autism spectrum disorders: self- and proxy-reported quality of life and adaptive functioning. Focus Autism Other Dev Disabl. 2014;30(1):57–64.CrossRef Clark BG, Magill-Evans JE, Koning CJ. Youth with autism spectrum disorders: self- and proxy-reported quality of life and adaptive functioning. Focus Autism Other Dev Disabl. 2014;30(1):57–64.CrossRef
17.
go back to reference Tamim H, McCusker JF, Dendukuri N, Dendukuri N: Proxy reporting of quality of life using the EQ-5D. (0025-7079 (Print)). Tamim H, McCusker JF, Dendukuri N, Dendukuri N: Proxy reporting of quality of life using the EQ-5D. (0025-7079 (Print)).
18.
go back to reference Williams Linda S, Bakas T, Brizendine E, Plue L, Tu W, Hendrie H, Kroenke K. How valid are family proxy assessments of stroke patients’ health-related quality of life? Stroke. 2006;37(8):2081–5.CrossRef Williams Linda S, Bakas T, Brizendine E, Plue L, Tu W, Hendrie H, Kroenke K. How valid are family proxy assessments of stroke patients’ health-related quality of life? Stroke. 2006;37(8):2081–5.CrossRef
19.
go back to reference Rand S, Caiels J: Using proxies to assess quality of life: a review of the issues and challenges. 2015. Rand S, Caiels J: Using proxies to assess quality of life: a review of the issues and challenges. 2015.
20.
go back to reference Becchi A, Rucci P, Placentino A, Neri G, de Girolamo G. Quality of life in patients withschizophrenia—comparison of self-report and proxyassessments. Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):397–401.CrossRef Becchi A, Rucci P, Placentino A, Neri G, de Girolamo G. Quality of life in patients withschizophrenia—comparison of self-report and proxyassessments. Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):397–401.CrossRef
21.
go back to reference Oktrinalida AM, Sahab A, Suryani PR. Kualitas Hidup Pasien Skizofrenia di Poliklinik Rawat Jalan Rumah Sakit Ernaldi Bahar Palembang. Sriwij J Med. 2019;2(2):68–75.CrossRef Oktrinalida AM, Sahab A, Suryani PR. Kualitas Hidup Pasien Skizofrenia di Poliklinik Rawat Jalan Rumah Sakit Ernaldi Bahar Palembang. Sriwij J Med. 2019;2(2):68–75.CrossRef
22.
go back to reference Idrus F, Limoa E, Honest I, Ganda IJ, Tammasse J, Syamsuddin S, Lisal ST: The effectiveness of the combination therapy of risperidone, Group Psychotherapy and occupational therapy on cognitive functions and the quality of life of schizophrenia patients. Indian J Public Health Res Dev 2019, 10(10). Idrus F, Limoa E, Honest I, Ganda IJ, Tammasse J, Syamsuddin S, Lisal ST: The effectiveness of the combination therapy of risperidone, Group Psychotherapy and occupational therapy on cognitive functions and the quality of life of schizophrenia patients. Indian J Public Health Res Dev 2019, 10(10).
23.
go back to reference Puspitosari WA, Wardaningsih S, Nanwani S. Improving the quality of life of people with schizophrenia through community based rehabilitation in Yogyakarta Province, Indonesia: A quasi experimental study. Asian J Psychiatr. 2019;42:67–73.CrossRef Puspitosari WA, Wardaningsih S, Nanwani S. Improving the quality of life of people with schizophrenia through community based rehabilitation in Yogyakarta Province, Indonesia: A quasi experimental study. Asian J Psychiatr. 2019;42:67–73.CrossRef
24.
go back to reference Rabin R, Gudex C, Selai C, Herdman M. From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value Health. 2014;17(1):70–6.CrossRef Rabin R, Gudex C, Selai C, Herdman M. From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value Health. 2014;17(1):70–6.CrossRef
25.
go back to reference Purba FD, Hunfeld JA, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Passchier J, Busschbach JJ. Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS ONE. 2018;13(5):e0197098.CrossRef Purba FD, Hunfeld JA, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Passchier J, Busschbach JJ. Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS ONE. 2018;13(5):e0197098.CrossRef
26.
go back to reference Indonesian Health Technology Assessment Committee (InaHTAC): Health Technology Assessment (HTA) Guideline. In: Jakarta: Pusat Pembiayaan dan Jaminan Kesehatan Kementerian Kesehatan RI; 2017: 143. Indonesian Health Technology Assessment Committee (InaHTAC): Health Technology Assessment (HTA) Guideline. In: Jakarta: Pusat Pembiayaan dan Jaminan Kesehatan Kementerian Kesehatan RI; 2017: 143.
27.
go back to reference Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13(2):261–76.CrossRef Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13(2):261–76.CrossRef
28.
go back to reference Salam R, Budiman R, Bastaman T, Yuniar S, Damping C, Kusumawardhani A, Purnamawati Y, Widyanto S. Pedoman definisi PANSS (positive and negative symptoms scale). Bagian Psikiatri: FK Universitas Indonesia; 1994. Salam R, Budiman R, Bastaman T, Yuniar S, Damping C, Kusumawardhani A, Purnamawati Y, Widyanto S. Pedoman definisi PANSS (positive and negative symptoms scale). Bagian Psikiatri: FK Universitas Indonesia; 1994.
29.
go back to reference Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213–20.CrossRef Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213–20.CrossRef
30.
go back to reference Purba FD, Hunfeld JAM, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Ramos-Goni JM, Passchier J, Busschbach JJV. The Indonesian EQ-5D-5L value set. Pharmacoeconomics. 2017;35(11):1153–65.CrossRef Purba FD, Hunfeld JAM, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Ramos-Goni JM, Passchier J, Busschbach JJV. The Indonesian EQ-5D-5L value set. Pharmacoeconomics. 2017;35(11):1153–65.CrossRef
31.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.CrossRef Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.CrossRef
32.
go back to reference Pickard AS, Johnson JF, Feeny DH, Feeny DF, Shuaib A, Shuaib AF, Carriere KC, Carriere KF, Nasser AM, Nasser AM: Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. 2004(1524–4628 (Electronic)). Pickard AS, Johnson JF, Feeny DH, Feeny DF, Shuaib A, Shuaib AF, Carriere KC, Carriere KF, Nasser AM, Nasser AM: Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. 2004(1524–4628 (Electronic)).
33.
go back to reference Devine A, Taylor SJC, Spencer A, Diaz-Ordaz K, Eldridge S, Underwood M. The agreement between proxy and self-completed EQ-5D for care home residents was better for index scores than individual domains. J Clin Epidemiol. 2014;67(9):1035–43.CrossRef Devine A, Taylor SJC, Spencer A, Diaz-Ordaz K, Eldridge S, Underwood M. The agreement between proxy and self-completed EQ-5D for care home residents was better for index scores than individual domains. J Clin Epidemiol. 2014;67(9):1035–43.CrossRef
34.
go back to reference Coucill W, Bryan S, Bentham P, Buckley A, Laight A. EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care. 2001;39(8):760–71.CrossRef Coucill W, Bryan S, Bentham P, Buckley A, Laight A. EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care. 2001;39(8):760–71.CrossRef
35.
go back to reference Dinglas VD, Gifford JM, Husain N, Colantuoni E, Needham DM. Quality of life before intensive care using EQ-5D: patient versus proxy responses. Crit Care Med. 2013;41(1):9–14.CrossRef Dinglas VD, Gifford JM, Husain N, Colantuoni E, Needham DM. Quality of life before intensive care using EQ-5D: patient versus proxy responses. Crit Care Med. 2013;41(1):9–14.CrossRef
36.
go back to reference Gamst-Klaussen T, Lamu AN. Does the EQ-5D usual activities dimension measure what it intends to measure? The relative importance of work, study, housework, family or leisure activities. Qual Life Res. 2020;29(9):2553–62.CrossRef Gamst-Klaussen T, Lamu AN. Does the EQ-5D usual activities dimension measure what it intends to measure? The relative importance of work, study, housework, family or leisure activities. Qual Life Res. 2020;29(9):2553–62.CrossRef
37.
go back to reference Jensen-Dahm C, Vogel A, Waldorff FB, Waldemar G. Discrepancy between self- and proxy-rated pain in Alzheimer’s disease: results from the Danish Alzheimer Intervention Study. J Am Geriatr Soc. 2012;60(7):1274–8.CrossRef Jensen-Dahm C, Vogel A, Waldorff FB, Waldemar G. Discrepancy between self- and proxy-rated pain in Alzheimer’s disease: results from the Danish Alzheimer Intervention Study. J Am Geriatr Soc. 2012;60(7):1274–8.CrossRef
38.
go back to reference Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D. Br J Psychiatry. 2009;195(2):170–7.CrossRef Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D. Br J Psychiatry. 2009;195(2):170–7.CrossRef
39.
go back to reference Kunz S. Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia. Qual Life Res. 2010;19(3):425–34.CrossRef Kunz S. Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia. Qual Life Res. 2010;19(3):425–34.CrossRef
Metadata
Title
EQ-5D-5L in Schizophrenia: differences between patients and nurses’ reports
Authors
Fredrick Dermawan Purba
Yusi Anggriani
Tri Murtini
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2021
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-021-01873-y

Other articles of this Issue 1/2021

Health and Quality of Life Outcomes 1/2021 Go to the issue